Patient Access Liaison
Viridian Therapeutics
Patient Access Liaison
Viridian Therapeutics
Develops miRNA-targeting therapies for autoimmune diseases
At Viridian, we work with a sense of urgency for patients, creating unity with our team, the industry, and the community. We are committed to using proven science and engineering to improve the lives of people living with serious and rare diseases, and we are getting closer to achieving this goal every day.
Reporting to the Director of Patient Access Liaisons, the Patient Access Liaison (PAL) provides logistical and non-medical education to patients, caregivers, physicians, nurses, office, and infusion center staff. The PAL is a member of Viridian’s Patient Services team and is responsible for executing strategies that enhance patient access to Viridian therapies by minimizing access barriers and ensuring a consistent, compliant, and high-quality support experience for patients. This role will be an integral part of product launch plans.
The PAL role is fully remote and covers the following areas: Washington DC, & Virginia. Travel for meetings and customer engagements may be required at the discretion of management.
Responsibilities (including but not limited to):
Qualifications:
Viridian offers a comprehensive benefits package including:
Viridian Therapeutics, Inc. provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination, harassment, or retaliation of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by Federal, State, and Local laws. Viridian will ensure that individuals with disabilities are provided reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request accommodation.
Viridian Therapeutics, Inc participates in E-Verify, the federal program for electronic verification of employment eligibility.
Applicant Privacy Notice: Information submitted in connection with your application will be processed in accordance with Viridian's Privacy Policy, available here.
Salary Range 190000 - 220000 USD
Develops miRNA-targeting therapies for autoimmune diseases
Viridian Therapeutics discovers and develops therapies that target microRNA (miRNA) pathways to treat autoimmune diseases, with a focus on thyroid eye disease. The company uses monoclonal antibody technology aimed at the IGF-1 receptor (IGF-1R) pathway to modulate disease biology. Its product approach integrates miRNA biology with antibody engineering to create treatments that intervene in autoimmune processes. The company differentiates itself by combining miRNA-targeting strategies with IGF-1R–focused monoclonal antibodies, operating in the clinical-stage space and concentrating on rare thyroid-related autoimmune conditions. Its goal is to advance clinical candidates through development toward regulatory approval and eventual market launch for patients who suffer from these diseases.
Explore more opportunities at Viridian Therapeutics